Industry Session
Kenneth Sims, Jr., PhD
Lead Materials Scientist
Battelle Memorial Institute
Columbus, Ohio, United States
Alexander Wesselhoeft, PhD
Director, HMS Instructor
Gene and Cell Therapy Institute (GCTI) at Mass General Brigham (MGB), Massachusetts, United States
Ashley Craddick, MBA
Forge Biologics
This session will highlight recent advances in innovative gene delivery technologies and how new techniques are overcoming known delivery challenges. The session will help attendees understand the current landscape of drug and gene delivery technologies while exploring emerging technologies and their potential impact to help patients. Both viral and non-viral methods will be discussed, though this session will primarily focus on how non-viral technologies may supplement or expand upon the current viral-based options in the delivery toolbox.